XML 75 R21.htm IDEA: XBRL DOCUMENT
v3.3.0.814

Pro Forma Information – Vitro Acquisition | 9 Months Ended
--- | ---
Sep. 30, 2015
Pro Forma Information – Vitro Acquisition |
Pro Forma Information – Vitro Acquisition | 16. Pro Forma Information – Vitro Acquisition Had the Vitro Acquisition, described in Note 15 and the related financing described in Note 8, occurred at the beginning of each respective period, unaudited pro forma consolidated net sales, earnings from continuing operations and earnings from continuing operations per share of common stock (diluted) would have been as follows:
|  | Three months ended September 30, 2015 |
|  | As |  | Acquisition |  | Financing |  | Pro Forma |
|  | Reported |  | Adjustments |  | Adjustments |  | As Adjusted |
Net sales | $ | 1,566 | $ | 143 | $ | — | $ | 1,709 |
Earnings from continuing operations attributable to the Company |  | 18 |  | 18 |  | (11) |  | 25 |
Diluted earnings per share from continuing operations |  | 0.11 |  |  |  |  |  | 0.15 |
|  | Nine months ended September 30, 2015 |
|  | As |  | Acquisition |  | Financing |  | Pro Forma |
|  | Reported |  | Adjustments |  | Adjustments |  | As Adjusted |
Net sales | $ | 4,530 | $ | 574 | $ | — | $ | 5,104 |
Earnings from continuing operations attributable to the Company |  | 131 |  | 79 |  | (46) |  | 164 |
Diluted earnings per share from continuing operations |  | 0.81 |  |  |  |  |  | 1.01 |
|  | Three months ended September 30, 2014 |
|  | As |  | Acquisition |  | Financing |  | Pro Forma |
|  | Reported |  | Adjustments |  | Adjustments |  | As Adjusted |
Net sales | $ | 1,745 | $ | 224 | $ | — | $ | 1,969 |
Earnings from continuing operations attributable to the Company |  | 61 |  | 25 |  | (18) |  | 68 |
Diluted earnings per share from continuing operations |  | 0.37 |  |  |  |  |  | 0.41 |
|  | Nine months ended September 30, 2014 |
|  | As |  | Acquisition |  | Financing |  | Pro Forma |
|  | Reported |  | Adjustments |  | Adjustments |  | As Adjusted |
Net sales | $ | 5,181 | $ | 651 | $ | — | $ | 5,832 |
Earnings from continuing operations attributable to the Company |  | 297 |  | 64 |  | (53) |  | 308 |
Diluted earnings per share from continuing operations |  | 1.79 |  |  |  |  |  | 1.85 |

X
- Definition Represents the information pertaining to disclosure of pro forma information related to acquisition. + References No definition available. + Details
Name: | oi_BusinessAcquisitionProFormaInformationDisclosureTextblock
Namespace Prefix: | oi_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionProFormaInformationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration